Return to Special Authority drug list
Generic name |
aclidinium |
---|---|
Strength & form |
400 mcg dry powder for oral inhalation |
Special Authority criteria |
Approval period |
---|---|
Diagnosis of chronic obstructive pulmonary disease (COPD) AND Failure after a minimum one-month trial of each of the Regular Benefit long-acting muscarinic receptor antagonist (LAMA) products1 |
Indefinite |